The Medibank (ASX:MPL) share price is up 18% so far in 2021. Here's why

Here's what's driven the Medibank share price this year.

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price has been having a great year so far on the ASX.

Perhaps more impressive, the health insurance and solutions company's gains have come despite it only releasing news a handful of times.

Right now, the Medibank shares are trading for $3.54 apiece, 17.28% higher than they were at the start of 2021.

Let's take a closer look at what the S&P/ASX 200 Index (ASX: XJO) company has been up to in 2021.

What's driven the Medibank share price in 2021?

It's been a good year for Medibank shares, despite the company keeping relatively quiet. Here's what we've heard from Medibank in 2021.

Myhealth acquisition

In early February, Medibank announced it had acquired a non-controlling 33.4% interest in Myhealth Medical Group.

Myhealth operates 86 primary care clinics scattered across Victoria, New South Wales, and Queensland.

According to Medibank, the investment strengthened its focus on preventive health and doctor-led partnerships.

The Medibank share price didn't react to the news.

Half yearly results

A matter of weeks later, Medibank released its results for the first half of financial year 2021.

For the 6 months ended 31 December 2020, Medibank recorded net profits after tax of $226.4 million, a 27.3% increase on those of the prior corresponding period.

It also reported that its income from premiums rose 0.3% to $3.3 billion, while its net claims expenses dropped $24.1 million – or 0.8%.

Medibank also announced a 5.8 cent fully franked dividend.

Finally, the company announced its CEO, Craig Drummond, was to retire. Medibank's new CEO David Koczkar took over the role on 17 May.

The Medibank share price fell 3.4% on the back of the results.

Returning money to customers

Lastly, in April Medibank announced that it plans to return around $105 million it's saved during COVID-19 to its customers.

According to Medibank, the savings came from its customers deferring their claims due to the global pandemic.

The Medibank share price fell 0.6% the day the company announced the give-back.

Medibank share price snapshot

After starting 2021 at $3.04, the Medibank share price is now $3.54.

It has also gained 24% since this time last year.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Health professional putting on gloves.
Healthcare Shares

How will Ansell shares navigate tariffs according to Macquarie?

The next two years could be a challenging period for the PPE company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is surging 18% on big news

This stock is getting a lot of love from investors on Monday.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Healthcare Shares

CSL shares are having a tough time recently. Are they a buy or a sell?

Is now a good time to jump in and buy this blue chip star?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why this fund manager is all in on Pro Medicus shares and recently increased his bet

This high-flying stock has suffered from turbulence.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Why I'm taking a closer look at ResMed shares

The ResMed share price hasn’t escaped recent market volatility. Is it time to buy?

Read more »

Health professional working on his laptop.
Healthcare Shares

Trump 2.0: Macquarie's take on the winners and losers in Australian healthcare

Let's see what the broker is saying about these healthcare stocks.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Own CSL shares? You're getting a dividend paycheque today

There's a silver lining to today's sell-off.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

How this Trump appointee could pressure the CSL share price

A leading expert believes Donald Trump isn’t doing CSL shareholders any favours.

Read more »